Somite AI

Somite.ai is an innovative biotechnology company focused on developing cell replacement therapies using artificial intelligence and big data. Their mission is to produce human tissue for medical treatments by creating a digital twin of the embryo, which simulates its development to optimize cell production protocols. Specializing in somite-derived cells, such as muscle and cartilage, Somite.ai aims to address various medical conditions, including metabolic diseases and muscular dystrophies. By leveraging AI, they enhance the efficiency and scalability of producing these critical cell types, setting them apart in the field of regenerative medicine.